H.R. 1108

Key Votes on H.R. 1108
Roll Call
About The Keyvote

The House bill includes language that allows the Food and Drug Administration (FDA) to impose new "user fees" to cover the costs of its expanded regulatory program. The user fee would no longer be a "fee for service' that covers the agency’s costs—it would be a new tax.